Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
Atrial fibrillation and renal dysfunction often coexist, each disorder may predispose to the other and contribute to worsening prognosis. Both atrial fibrillation and chronic kidney disease are associated with increased risk of stroke and thromboembolic complications. Oral anticoagulation for stroke...
Saved in:
Main Authors: | Z. D. Kobalava (Author), A. A. Shavarov (Author), M. V. Vatsik-Gorodetskaya (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING
by: Zh. D. Kobalava, et al.
Published: (2018) -
Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
by: Soo Min Jang, et al.
Published: (2020) -
Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation
by: S. V. Malchikova, et al.
Published: (2020) -
Gastrointestinal protection options for direct oral anticoagulants in patients with atrial fibrillation
by: Natalya M. Vorobyeva, et al.
Published: (2022) -
Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: V. I. Petrov, et al.
Published: (2019)